Vee Healthtek Joins TA Associates’ Portfolio with Strategic Growth Investment

NEW YORK, Nov. 19, 2024 /PRNewswire/ — Today, TA Associates (“TA”), a global growth private equity firm, has announced a majority stake investment in Vee Healthtek, the former healthcare professional services division of Vee Technologies. Now a TA portfolio company, Vee Healthtek will enhance its client-focused healthcare solutions and operations through expanded offerings, increased resources, and cutting-edge technology.

TA, known for its expertise in scaling global companies, recognizes the immense potential for expansion within the dynamic healthcare sector. Through its investment, the firm will leverage its record of success to fuel extraordinary growth and innovation for Vee Healthtek and its clients.

As a partner to top payers and providers, Vee Healthtek delivers end-to-end solutions with AI, automation, and machine learning functionalities that streamline operations, enhance financial performance, and support the delivery of exceptional patient care. Its best-in-class, technology-enabled offerings, including revenue cycle management, health information management, business intelligence and analytics, risk adjustment, and claims management, ensure that the healthcare organizations Vee Healthtek serves receive unparalleled accuracy and quality.

The synergy between Vee Healthtek’s domain knowledge and TA’s strategic vision signifies the start of a robust relationship that is poised to set new benchmarks in healthcare. With access to TA’s technology, resources, and networks, Vee Healthtek anticipates diversifying its suite of services, enhancing capabilities, and capturing an even greater market share of the healthcare sector.

“TA’s wealth of knowledge will allow us to take the scope and sophistication of our services to new heights.” Matt Michaels, CEO of Vee Healthtek, commented. “Alongside TA, we will unlock an expanded realm of possibilities for our clients. The forecast is extremely promising, and I am eager to see what we can accomplish together. With TA’s support and guidance, Vee Healthtek will scale faster than ever imaginable.”

This partnership marks a pivotal moment in the healthcare sector. Vee Healthtek and TA are positioned to transform the future of the industry by harnessing their unique strengths and insights. Together, they will drive revolutionary outcomes for patients, payers, and providers alike.

About Vee Healthtek:
Vee Healthtek is a leading professional services provider and strategic partner to the nation’s top healthcare organizations. Rooted in a history of innovation, Vee Healthtek offers industry-best results backed by data and technology. With a comprehensive suite of end-to-end solutions, the firm delivers excellence in healthcare business process outsourcing services. For more information, please visit www.veehealthtek.com

About TA Associates:
TA is a leading global private equity firm focused on scaling growth in profitable companies. Since 1968, TA has invested in more than 560 companies across its five target industries – technology, healthcare, financial services, consumer and business services. Leveraging its deep industry expertise and strategic resources, TA collaborates with management teams worldwide to help high-quality companies deliver lasting value. The firm has raised $65 billion in capital to date and has over 150 investment professionals across offices in Boston, Menlo Park, Austin, London, Mumbai and Hong Kong. For more information, visit: www.ta.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/vee-healthtek-joins-ta-associates-portfolio-with-strategic-growth-investment-302309977.html

SOURCE Vee Healthtek

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

13 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

16 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

16 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

16 hours ago